Asset Details
Do you wish to reserve the book?
Perspectives of substance use disorder counselors on the benefits and drawbacks of medications for opioid use disorder
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Perspectives of substance use disorder counselors on the benefits and drawbacks of medications for opioid use disorder
Do you wish to request the book?
Perspectives of substance use disorder counselors on the benefits and drawbacks of medications for opioid use disorder
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Perspectives of substance use disorder counselors on the benefits and drawbacks of medications for opioid use disorder
2025
Overview
Background
Medications for opioid use disorder (MOUD) are among the best tools available to combat the opioid epidemic. Yet, use of MOUD among people with opioid use disorder (OUD) remains low. Interventions to increase MOUD access in the United States have largely focused on improving organizational capacity and addressing funding barriers, yet stigma toward MOUD may inhibit uptake even where MOUD is readily available. Non-prescribing substance use disorder (SUD) treatment professionals (e.g. counselors) likely have considerable influence on a client’s choice to initiate and adhere to MOUD, but beliefs that counselors convey about MOUD in interaction with clients are understudied. The current study explores what advantages and disadvantages that counselors communicate about buprenorphine, methadone, and naltrexone.
Methods
From June to December 2021, we surveyed counselors from publicly-funded SUD treatment agencies under a municipality-wide mandate to offer MOUD to all clients with OUD. Counselors were asked to describe, in a free-response format, the most important advantages and disadvantages to communicate to their clients about taking buprenorphine, methadone, and naltrexone. Counselor responses were coded for one or more advantage and disadvantage.
Results
A total of 271 SUD counselors from 29 agencies in the Philadelphia Metropolitan Area completed the survey, generating 1,995 advantages and disadvantages across three types of MOUD. The most frequently reported advantage across all three types of MOUD was their ability to reduce cravings and illicit drug use. The most frequently reported disadvantage related to the potential for some types of MOUD to develop long-term medication dependence.
Conclusions
As the availability and variety of MOUD treatment options continue to expand, it is important that SUD counselors are equipped with evidence-based recommendations for OUD care. We identified misalignments with the MOUD-prescribing evidence base and stigmatizing language toward MOUD within counselors’ responses, highlighting the potential to refine training materials for MOUD and mitigate stigmatizing beliefs.
Publisher
BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
Subject
/ Analgesics, Opioid - therapeutic use
/ Attitude of Health Personnel
/ Buprenorphine - therapeutic use
/ Clients
/ Drug use
/ Drugs
/ Female
/ Humans
/ Male
/ Medicaid
/ Medications for opioid use disorder
/ Medicine
/ MOUD
/ Naltrexone - therapeutic use
/ Narcotic Antagonists - therapeutic use
/ Opiate Substitution Treatment - methods
/ Opioid-Related Disorders - drug therapy
/ Opioids
/ Stigma
/ Substance use disorder counselors
/ Uptake
